Now that the Food and Drug Administration has again delayed over-the-counter sale of the morning-after pill Plan B, new lobbying efforts are underway to make the drug widely available. This report, published in May 30, provides useful background on how the personal ideology of Bush appointees is adversely affecting the health and welfare of women.
Late last October Dr. W. David Hager, a prominent obstetrician-gynecologist and Bush Administration appointee to the Advisory Committee for Reproductive Health Drugs in the Food and Drug Administration (FDA), took to the pulpit as the featured speaker at a morning service. He stood in the campus chapel at Asbury College, a small evangelical Christian school nestled among picturesque horse farms in the small town of Wilmore in Kentucky’s bluegrass region. Hager is an Asburian nabob; his elderly father is a past president of the college, and Hager himself currently sits on his alma mater’s board of trustees. Even the school’s administrative building, Hager Hall, bears the family name.
That day, a mostly friendly audience of 1,500 students and faculty packed into the seats in front of him. With the autumn sunlight streaming through the stained-glass windows, Hager opened his Bible to the Old Testament Book of Ezekiel and looked out into the audience. “I want to share with you some information about how…God has called me to stand in the gap,” he declared. “Not only for others, but regarding ethical and moral issues in our country.”
For Hager, those moral and ethical issues all appear to revolve around sex: In both his medical practice and his advisory role at the FDA, his ardent evangelical piety anchors his staunch opposition to emergency contraception, abortion and premarital sex. Through his six books–which include such titles as Stress and the Woman’s Body and As Jesus Cared for Women, self-help tomes that interweave syrupy Christian spirituality with paternalistic advice on women’s health and relationships–he has established himself as a leading conservative Christian voice on women’s health and sexuality.
And because of his warm relationship with the Bush Administration, Hager has had the opportunity to see his ideas influence federal policy. In December 2003 the FDA advisory committee of which he is a member was asked to consider whether emergency contraception, known as Plan B, should be made available over the counter. Over Hager’s dissent, the committee voted overwhelmingly to approve the change. But the FDA rejected its recommendation, a highly unusual and controversial decision in which Hager, The Nation has learned, played a key role. Hager’s reappointment to the committee, which does not require Congressional approval, is expected this June, but Bush’s nomination of Dr. Lester Crawford as FDA director has been bogged down in controversy over the issue of emergency contraception. Crawford was acting director throughout the Plan B debacle, and Senate Democrats, led by Hillary Clinton and Patty Murray, are holding up his nomination until the agency revisits its decision about going over the counter with the pill.